- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 371, Issue 23, Pages 2200-2206
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2014-12-04
DOI
10.1056/nejmoa1400284
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- Updates on apolipoprotein CIII
- (2013) Chunyu Zheng CURRENT OPINION IN LIPIDOLOGY
- Response to Comment on: Korpos et al. The Peri-islet Basement Membrane, a Barrier to Infiltrating Leukocytes in Type 1 Diabetes in Mouse and Human. Diabetes 2013;62:531–542
- (2013) Éva Korpos et al. DIABETES
- Antisense Technology: An Emerging Platform for Cardiovascular Disease Therapeutics
- (2013) Richard G. Lee et al. Journal of Cardiovascular Translational Research
- Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production
- (2012) Zemin Yao et al. CURRENT OPINION IN LIPIDOLOGY
- Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
- (2012) D Gaudet et al. GENE THERAPY
- Severe hypertriglyceridemia
- (2012) W. Virgil Brown et al. Journal of Clinical Lipidology
- Mutations inLPL,APOC2,APOA5,GPIHBP1andLMF1in patients with severe hypertriglyceridaemia
- (2012) R. P. Surendran et al. JOURNAL OF INTERNAL MEDICINE
- Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease
- (2011) Carlos O. Mendivil et al. CIRCULATION
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
- (2011) et al. EUROPEAN HEART JOURNAL
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Prevalence, clinical characteristics and treatment patterns of low high-density lipoprotein cholesterol in the US population
- (2011) Jennifer B. Christian et al. Journal of Cardiovascular Medicine
- Etiology and risk of lactescent plasma and severe hypertriglyceridemia
- (2010) Karine Tremblay et al. Journal of Clinical Lipidology
- Genetic determinants of plasma triglycerides
- (2010) Christopher T. Johansen et al. JOURNAL OF LIPID RESEARCH
- Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease
- (2010) Kitt Falk Petersen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
- (2008) Esther M. M. Ooi et al. CLINICAL SCIENCE
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
- (2008) T. I. Pollin et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now